ArticleFrontiers in public health2024
Validity and reliability of local endemic language version of the SARI Sigma Scale questionnaire for assessing stigma in leprosy patients.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Quality of life, stigma, and mental health, in individuals affected by leprosy: a cross-sectional study.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026Article
- The adaptation and psychometric validation of a stigma measure for adults diagnosed with severe vision impairment in rural Mozambique.BMC psychology · 2026Article
- Serological Evidence of Soil-Transmitted Helminth Infections as a Potential Risk for Severity in Leprosy Patients.Tropical medicine & international health : TM & IH · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Stigma Assessment and Reduction of Impact (SARI) Stigma Scale is an instrument developed to evaluate stigma in Leprosy patients. Despite existing versions in Indonesian, the absence of an endemic area language version of a reliable assessment tool presents a barrier to effective interventions in regions like Ambon. This study aims to evaluate the validity and reliability of the Ambonese-Malay Language of SARI Stigma Scale questionnaire. Methods: A cross-sectional study involved 50 participants with leprosy or a history of leprosy from Ambon City, Indonesia. They were tested with the SARI Stigma Scale questionnaire, consisting of 4 domains of questions, totalling 21 questions. Reliability and variability analysis was conducted from each domain's questions. Cronbach's α (CA) and intraclass correlation coefficient (ICC) determined internal consistency of reliability tests. For validity assessment, coefficients of corrected item-total correlation ensured scale accuracy for measuring stigma. Results: Reliability analysis revealed significant high internal consistency (α and ICC value >0.7) across all four domains, with CA values ranging from 0.71 to 0.94 and strong consistency among responses, with ICC ranging from 0.71 to 0.94 across domains. The total domain exhibited a CA of 0.855 and an average ICC of 0.855 ( Discussion: The Ambonese-Malay version of the SARI Stigma Scale exhibits validity and reliability as an assessment tool for scoring stigma in leprosy patients in Ambon. Stigma can emerge and be associated with leprosy. To understand the stigma in society due to this disease, a validated questionnaire in the local language and adjusted with the local cultures needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.